Soltan Ahmed Ebrahimi (Soltan Ahmad Ebrahimi, Soltan A Ebrahimi)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Molecularly Imprinted

Replacement Therapy

Vascular Endothelial Growth Factor

Top Venues

Drug development research

Journal of inherited metabolic disease

Basic and clinical neuroscience

Evidence-based complementary and alternative medicine : eCAM

Iran University of Medical Sciences

University of Portsmouth (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Iran University of Medical Sciences Feb 26 1995

Iran

Associate Professor :: Pharmacology

Education History

University of Portsmouth Jun 11 1990 - Jun 11 1994

United Kingdom

PHD :: Pharmacy and Biomedical Sciences

Publications

Mansour Torab, Majid Jafari-Sabet, Parvaneh Najafizadeh, Alireza Sadegipour, Parvaneh Rahimi-Moghaddam, Soltan Ahmed Ebrahimi
Oral administration of phenylalanine molecularly imprinted polymer (MIP) benefits PKU mouse model. Journal of inherited metabolic disease 45 (4) (2022)
Arash Nikkholgh, Soltan Ahmed Ebrahimi, Enayatollah Bakhshi, Mohammad-Reza Zarrindast, Yazdan Asgari, Anahita Torkaman-Boutorabi
New Biomarkers Based on Smoking-Related Phenotypes for Smoking Cessation Outcomes of Nicotine Replacement Therapy: A Prospective Study. Basic and clinical neuroscience 12 (5) (2021)
Soltan Ahmed Ebrahimi
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2. Drug development research 81 (7) (2020)
Foad Ghazizadeh, Massoumeh Shafiei, Reza Falak, Mahshid Panahi, Naser Rakhshani, Soltan Ahmed Ebrahimi, Parvaneh Rahimi-Moghaddam
Xanthomicrol Exerts Antiangiogenic and Antitumor Effects in a Mouse Melanoma (B16F10) Allograft Model. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)